Correlation Between OCT and Mf-ERG Findings With BCVA in Patients With Macular Dystrophy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: OCT ,mFERG,VA test.
- Who it may be relevant to
- Registry conditions: Macular Dystrophy. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Correlation Between Optical Coherence Tomography and Multifocal Electroretinogram Findings With Visual Acuity in Patients With Macular Dystrophy
Overview
Correlation between optical coherence tomography and multifocal electroretinogram findings with visual acuity in patients with macular dystrophy.
Detailed description
Macular dystrophies cause progressive central vision loss, but the relationship between structural retinal changes (OCT) and functional deficits (mf-ERG) with visual outcomes remains poorly understood. Current clinical assessment relies primarily on visual acuity, which inadequately reflects retinal damage or predicts disease progression. This knowledge gap limits prognostic accuracy and optimal patient management. Recent advances in OCT and mf-ERG technology provide an opportunity to establish robust structure-function correlations. Understanding these relationships will enhance patient care through improved prognosis, standardized monitoring protocols, and better clinical trial outcome measures for macular dystrophy patients.
Interventions
- Diagnostic test OCT ,mFERG,VA test
retinal photography by OCT, VA measurement, and mfERG test
Primary outcome measures
- BCVA (best corrected visual acuity) [Time frame: Day 1/month 3]
- CMT (central macular thickness) μm Central macular thickness measurement using optical coherence tomography [Time frame: Day1/month 3]
- mf-ERG amplituide nV/deg2 [Time frame: Day 1/month 6]
Eligibility criteria
Inclusion criteria
- All patients diagnosed with macular dystrophy in Tiba Eye Centre, Egypt, Assiut, during the period of the study
Exclusion criteria
- The patients diagnosed with macular dystrophy refuse to contribute to the study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07171541 · CBOTMEFVAPMD